Tobramycinformulierung

Patent europeic · EP2662093 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2662093
Numer da la dumonda
EP13002039
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
18-04-2013
Publitgà
13-11-2013
Concedì
14-01-2015
La protecziun finescha il pli tard
17-04-2033
Proxima taxa annuala scadenta
30-04-2026
Classas IPC
A61K 47/12 (2006.01)
A61K 9/08 (2006.01)
A61K 31/7036 (2006.01)
A61K 9/72 (2006.01)
A61K 9/00 (2006.01)
Prioritad
US 201261644700 P 09.05.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  2. 01-05-2024

    Midada

    Published in Swissreg on 01.05.2024

  3. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  4. 14-01-2015

    Concedì

    Published in Swissreg on 14.01.2015

Partidas

Possessur

Norton Healthcare Limited

NORTON HEALTHCARE LIMITED

Regent House 5-7 Broadhurst Gardens, Swiss Cottage London NW6 3RZ, GB

Inventur

Higham, David

Runcorn, WA7 3FA, GB

Hawkins, Kevin

Runcorn, WA7 3FA, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.